/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

Acurx Pharmaceuticals Inc Share Price Today: Live Updates & Key Insights

Acurx Pharmaceuticals Inc share price today is $5.73, up -15.54%. The stock opened at $6.6 against the previous close of $6.63, with an intraday high of $6.6 and low of $5.4.

Acurx Pharmaceuticals Inc Share Price Chart

style
pb-0

Acurx Pharmaceuticals Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

Acurx Pharmaceuticals Inc Share Price Performance

$5.73 -0.1554(-15.54%) ACXP at 23 Mar 2026 11:53 AM Biotechnology
Lowest Today 5.4
Highest Today 6.6
Today’s Open 6.6
Prev. Close 6.63
52 Week High 21.00
52 Week Low 1.33
Day’s Range: Low 5.4 High 6.6
52-Week Range: Low 1.33 High 21.00
1 day return -
1 Week return +15.61
1 month return +238.78
3 month return +59.71
6 month return +37.68
1 year return +1192.48
3 year return +56.14
5 year return -29.06
10 year return -

Acurx Pharmaceuticals Inc Institutional Holdings

Millennium Management LLC 1.63

Vanguard Group Inc 0.91

Prospect Financial Services Llc 0.78

NT Ext Equity Mkt Idx Fd - L 0.65

Geode Capital Management, LLC 0.49

Jane Street Group LLC 0.42

Fidelity Extended Market Index 0.36

Vanguard Institutional Extnd Mkt Idx Tr 0.28

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.25

Morgan Stanley - Brokerage Accounts 0.21

Tower Research Capital LLC 0.11

Nbc Securities Inc 0.06

GPS Wealth Strategies Group, LLC 0.05

Spartan Total Market Index Pool G 0.04

Fidelity Total Market Index 0.04

Fidelity Series Total Market Index 0.04

Northern Trust Extended Eq Market Idx 0.04

Citigroup Inc 0.02

NT Ext Equity Mkt Idx Fd - NL 0.02

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.01

Group One Trading, LP 0.01

Cornerstone Planning Group LLC 0.01

Fidelity Nasdaq Composite Index 0.01

Advisor Group Holdings, Inc. 0.00

Bank of America Corp 0.00

BlackRock Inc 0.00

Advisory Services Network, LLC 0.00

State St US Extended Mkt Indx NL Cl C 0.00

SSgA U.S. Total Market Index Strategy 0.00

Northern Trust Wilshire 5000 0.00

NT US Market Cap Idx Fd - L 0.00

Sontag Advisory LLC 0.00

SBI Securities Co Ltd 0.00

Fidelity U.S. Equity Index Ins Trust 0.00

State Street Corp 0.00

Susquehanna International Group, LLP 0.00

Acurx Pharmaceuticals Inc Market Status

Strong Buy: 1

Buy: 2

Hold: 0

Sell: 0

Strong Sell: 0

Acurx Pharmaceuticals Inc Fundamentals

Market Cap 15.99 M

PB Ratio 3.0211

PE Ratio 0.0

Enterprise Value 8.36 M

Total Assets 7689.54 M

Volume 1006492

Acurx Pharmaceuticals Inc Company Financials

Annual Revenue FY23:0 0.0M, FY22:0 0.0M, FY21:0 0.0M, FY20:0 0.0M, FY19:0 0.0M

Annual Profit FY23:null 0.0M, FY22:null 0.0M, FY21:null 0.0M, FY20:null 0.0M, FY19:null 0.0M

Annual Net worth FY23:-12723689 -12.7M, FY22:-12091552 -12.1M, FY21:-12681194 -12.7M, FY20:-4600038 -4.6M, FY19:-5931253 -5.9M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q3/2024:0 0.0M, Q2/2024:0 0.0M

Quarterly Profit Q3/2025:null 0.0M, Q2/2025:null 0.0M, Q1/2025:null 0.0M, Q3/2024:null 0.0M, Q2/2024:null 0.0M

Quarterly Net worth Q3/2025:-1992790 -2.0M, Q2/2025:-2246279 -2.2M, Q1/2025:-2149193 -2.1M, Q3/2024:-2821597000 -2821.6M, Q2/2024:-4121826 -4.1M

About Acurx Pharmaceuticals Inc & investment objective

Company Information Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus (MRSA), vancomycin resistant enterococcus (VRE), and drug-resistant streptococcus pneumoniae (DRSP), as well as B. anthracis. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.

Organisation Biotechnology

Employees 4

Industry Biotechnology

CEO null

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow

Acurx Pharmaceuticals Inc FAQs

What is the share price of Acurx Pharmaceuticals Inc today?

The current share price of Acurx Pharmaceuticals Inc is $5.73.

Can I buy Acurx Pharmaceuticals Inc shares in India?

Yes, Indian investors can buy Acurx Pharmaceuticals Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Acurx Pharmaceuticals Inc shares in India?

You can easily invest in Acurx Pharmaceuticals Inc shares from India by:

Can I buy fractional shares of Acurx Pharmaceuticals Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Acurx Pharmaceuticals Inc?

Acurx Pharmaceuticals Inc has a market cap of $15.99 M.

In which sector does Acurx Pharmaceuticals Inc belong?

Acurx Pharmaceuticals Inc operates in the Biotechnology sector.

What documents are required to invest in Acurx Pharmaceuticals Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Acurx Pharmaceuticals Inc?

The PE ratio of Acurx Pharmaceuticals Inc is N/A and the PB ratio is 3.02.